Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists

Molecular Endocrinology

Volumn 12, Issue 5, 1998, Pages 654-663

  Gao, T ^a   McPhaul, M J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; FLUTAMIDE; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; HYDROXYFLUTAMIDE; ISOPROTEIN; METHIONINE; MIBOLERONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE FUNCTION; GENE STRUCTURE; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

EID: 0032230329     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.5.0112     Document Type: Article

References (43)

1. The steroid and thyroid hormone receptor superfamily
2. The nuclear receptor superfamily: The second decade
3. Cloning of human androgen receptor complementary DNA and localization to the X chromosome
4. Molecular cloning of human and rat complementary DNA encoding androgen receptors
5. Cloning, structure and expression of a cDNA encoding the human androgen receptor
6. Characterization and expression of a DNA encoding the human androgen receptor
7. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation
8. A and B forms of the androgen receptor are present in human genital skin fibroblasts
9. A and B forms of the androgen receptor are expressed in a variety of human tissues
10. Human progesterone receptor A form is a cell - and promoter-specific repressor of human progesterone receptor B function
11. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity
12. Agonist and antagonist activities of RU 486 on the functions of the human progesterone receptor
13. The N-terminal region of the chicken progesterone receptor specifies target gene activation
14. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms
15. Progesterone receptor-induced bending of its target DNA: Distinct effects of the A and B receptor forms
16. The scanning model for translation: An update
17. Defective up-regulation of the androgen receptor in human androgen insensitivity
18. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells
19. Steroid receptor family: Structure and functions
20. Superfamily of steroid nuclear receptors: Positive and negative regulators of gene expression
21. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?
22. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform
23. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of CAT expression by anti-androgens
24. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization
25. Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization
26. 1 pituitary tumor cells are gene specific
27. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
28. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
29. Hormone and antihormone induce distinct conformational change which are central to steroid receptor activation
30. Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states
31. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
32. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
33. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
34. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor
35. A new interpretation of antiestrogen action
36. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
37. A biological profile of a nonsteroidal antiandrogen Sch 13521 (4'-nitro-trifluor-methy-lisobutyranillide)
38. The effect of the non-steroidal antiandrogen flutamide on neural receptor binding of testosterone and intermale aggressive behaviour of mice
39. On the mechanism of the anti-androgenic action of flutamide (Trifluoro-2-methyl-4'-nitro-m-propionotoluidide) in the rat
40. Disposition of a new, nonsteroid, antiandrogen (flutamide), in men following a single oral 200 mg dose
41. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
42. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability
43. Transcription transactivation and transient expression of the human androgen receptor